Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.24.11 (
CD10
)
9,792
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Porphyromonas gingivalis secretes
endopeptidase
gingipains, which are important virulence factors of this bacterium. Gingipains are transported across the inner membrane via the Sec system, followed by transport across the outer membrane via an unidentified pathway. The latter transport step is suggested to be mediated via a novel protein secretion pathway. In the present study, we report a novel candidate as an essential factor for the latter transport step. The PG0027 gene of P. gingivalis W83 encodes novel protein PG27. In a PG0027 deletion mutant (83K10), the activities of Arg-gingipain and Lys-gingipain were severely reduced, while the activities of secreted exopeptidases DPPIV, DPP-7, and
PTP-A
were unaffected. Protein localization was investigated by cell-surface biotinylation, subcellular fractionation, and immunoblot analysis. In the wild-type W83, Arg-gingipains in membrane fraction were detected as cell surface proteins. In contrast, in 83K10, Arg-gingipains were trapped in the periplasm and hardly secreted into an extracellular milieu. PG27 was suggested to be exposed to the cell surface by a cell surface biotinylation experiment; however, PG27 was detected in both inner and outer membrane fractions by subcellular fractionation experiments. Taken together, we suggest that PG27 is a unique membrane protein essential for a novel secretion pathway.
...
PMID:PG27 is a novel membrane protein essential for a Porphyromonas gingivalis protease secretion system. 1918 1
Tripeptidyl-peptidase II (
TPP
II) is a giant cytosolic peptidase with a proposed role in cellular protein degradation and protection against apoptosis. Beside its well-characterised exopeptidase activity,
TPP
II also has an
endopeptidase
activity. Little is known about this activity, and since it could be important for the physiological role of
TPP
II, we have investigated it in more detail. Two peptides, Nef(69-87) and LL37, were incubated with wild-type murine
TPP
II and variants thereof as well as
TPP
II from human and Drosophila melanogaster. Two intrinsically disordered proteins were also included in the study. We conclude that the
endopeptidase
activity is more promiscuous than previously reported. It is also clear that
TPP
II can attack longer disordered peptides up to 75 amino acid residues. Using a novel FRET substrate, the catalytic efficiency of the
endopeptidase
activity could be determined to be 5 orders of magnitude lower than for the exopeptidase activity.
...
PMID:Characterization of the endopeptidase activity of tripeptidyl-peptidase II. 2277 4